|Primary Industry:||Health & Medical Devices|
|Executive Summary:||The Vision:
The vision of the company is to create superior, advanced, innovative, and cost-effective medical technologies which will replace existing medical diagnostic laboratory systems. The company will implement nano/micro-electro-mechanical systems (N/MEMS) technology, also known as nanofabrication/Nano-technology, in order to achieve its goals of creating superior medical systems.
The mission of the company is to create a technological platform for very rapid, cost-effective, disposable, stand-alone on the spot testing. In the first stage we intend to produce MEMS diagnostic chip for blood banks to type and crossmatch blood, a test performed more than 750 million times a year, globally. This chip and hand-held reader is intended to replace the slow, expensive systems, requiring much resources and reagents, which are used by current blood banks. Furthermore, our system platform is intended to screen, on the spot, blood donors for infectious diseases. |
|Venture is:||Seed Level|